Carcinoma in situ of digestive organ, unspecified
ICD-10 D01.9 is a billable code used to indicate a diagnosis of carcinoma in situ of digestive organ, unspecified.
Carcinoma in situ (CIS) of the digestive organ refers to a localized cancerous condition where abnormal cells are present in the lining of the digestive tract but have not invaded deeper tissues or spread to other parts of the body. This condition is often asymptomatic and may be discovered incidentally during routine examinations or imaging studies. The digestive organs include the esophagus, stomach, intestines, liver, pancreas, and rectum. Surveillance protocols for patients diagnosed with CIS typically involve regular endoscopic evaluations, imaging studies, and biopsies to monitor for progression to invasive cancer. The risk of progression varies depending on the specific organ involved, the histological type of carcinoma, and patient factors such as age and comorbidities. Early detection and intervention are crucial, as timely treatment can significantly improve outcomes and reduce the risk of developing invasive cancer.
Detailed pathology reports, imaging studies, and treatment plans.
Diagnosis of carcinoma in situ during routine screenings or imaging.
Ensure clear documentation of the type of carcinoma and its location.
Endoscopy reports, biopsy results, and follow-up care notes.
Surveillance of patients with a history of gastrointestinal carcinoma in situ.
Document the rationale for surveillance intervals and any findings during procedures.
Used for surveillance in patients with carcinoma in situ of the colon.
Document findings, biopsies taken, and follow-up plans.
Gastroenterologists should ensure thorough documentation of the procedure and findings.
Carcinoma in situ is a localized cancer that has not invaded surrounding tissues. It is often detected early and can be treated effectively to prevent progression to invasive cancer.
Patients with carcinoma in situ are typically monitored through regular imaging studies, endoscopic evaluations, and biopsies to assess for any changes or progression.
